Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 16,034	$ 8,363	$ 29,522	$ 15,618
General and administrative	4,302	3,852	8,453	7,615
Total operating expenses	20,336	12,215	37,975	23,233
Loss from operations	(20,336)	(12,215)	(37,975)	(23,233)
Other income (expense):
Interest income	1,312	230	2,432	338
Other expense	(1)	(6)	(2)	(6)
Total other income	1,311	224	2,430	332
Net loss	(19,025)	(11,991)	(35,545)	(22,901)
Comprehensive loss:
Net loss	(19,025)	(11,991)	(35,545)	(22,901)
Other comprehensive loss:
Unrealized gain (loss) on securities	(22)	(141)	243	(726)
Comprehensive loss	$ (19,047)	$ (12,132)	$ (35,302)	$ (23,627)
Net loss per share, basic	$ (0.76)	$ (0.49)	$ (1.42)	$ (0.94)
Net loss per share, diluted	$ (0.76)	$ (0.49)	$ (1.42)	$ (0.94)
Weighted-average shares of common stock outstanding, basic	25,166,505	24,410,503	24,973,250	24,410,448
Weighted-average shares of common stock outstanding, diluted	25,166,505	24,410,503	24,973,250	24,410,448